Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2023/03/050324
CTRI/2023/03/050324Not yet recruitingUnknown

An Uncontrolled Experimental Study To Assess The Effectiveness of Solanum Xanthocarpus In Management Of Urolithiasis

Swasthya Kalyan Homoeopathic Medical College And Research Centre Jaipur0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1.Pre- diagnosed and newly diagnosed cases of urolithiasis (symptomatic and asymptomatic ) with radiological evidence ultrasound (KUB region)
  • •2. Stones with no history of expulsion along with persistent symptomatology after radiological investigation

Exclusion Criteria

  • •1.Cases of urinary calculi with severe hydronephrosis, uraemia and acute retention of urine for more than 24 hours.
  • •2. Gross developmental defects or structural abnormality of kidney.
  • •3. Pregnant women and lactating mothers.
  • •4. Cases with advanced pathological condition ( systemic condition).

Investigators

Sponsor
Swasthya Kalyan Homoeopathic Medical College And Research Centre Jaipur

Similar Trials

Not yet recruiting
Unknown
EFFICACY OF ARNICA MONTANA IN MANAGEMENT OF PAIN INTENSITY IN MIGRAINE
CTRI/2023/03/050973itiksha Sharma
Not yet recruiting
Unknown
EFFICACY OF HOMOEOPATHIC MOTHER TINCTURE JABORANDI USE IN CASES OF HAIR FA
CTRI/2023/04/051454PRAKASH
Completed
Not Applicable
A randomized controlled study for evaluating the effects of a psychoeducational program for parents with cerebral palsy childreparents with cerebral palsy children
JPRN-UMIN000030824eurorehabilitation Research Institute, Morinomiya Hospital70
Active, not recruiting
Phase 1
A Randomized, Rater-Blinded Study to Explore the Effect of Mefloquine in Subjects with Progressive Multifocal Leukoencephalopathy (PML)Progressive Multifocal Leukoencephalopathy (PML)MedDRA version: 9.1Level: LLTClassification code 10036807Term: Progressive multifocal leukoencephalopathy
EUCTR2008-001314-24-FRBiogen Idec Ltd40
Active, not recruiting
Not Applicable
A Randomized, Rater-Blinded Study to Explore the Effect of Mefloquine in Subjects with Progressive Multifocal Leukoencephalopathy (PML) - ND
EUCTR2008-001314-24-ITBIOGEN IDEC LTD40